Hepatitis -Glaucoma is a leading cause of irreversible blindness worldwide, primarily caused by damage to the optic nerve. Elevated intraocular pressure (IOP) is one of the most significant risk factors for glaucoma progression….
Asthma -Asthma affects millions of people worldwide, causing chronic inflammation of the airways and making breathing difficult. Despite advances in inhalers and medications, many patients continue to experience…
Leqembi Found Safe for Use in Memory Clinics: A Step Forward in Alzheimer’s Treatment Accessibility. Leqembi (lecanemab), a monoclonal antibody developed by Eisai and Biogen, has recently been recognized as safe for use in memory clinics, marking a significant advancement in the treatment of early-stage Alzheimer’s disease
A new experimental drug is showing promise in slowing the progression of disability in individuals with multiple sclerosis (MS), according to recent findings from a large clinical trial. The results have sparked optimism among patients, neurologists, and researchers alike, as current treatment options for MS often focus primarily on managing symptoms rather than significantly altering the course of the disease.
Cholesterol management is a critical aspect of cardiovascular health, as high cholesterol levels can lead to serious conditions such…
Alzheimer’s disease, a progressive neurodegenerative disorder, affects millions of people worldwide, leading to memory loss, cognitive…
The U.S. Food and Drug Administration (FDA) has officially approved Tremfya (guselkumab) for the treatment of adults suffering from…
Stroke is one of the leading causes of disability and death worldwide, with ischemic stroke accounting
Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease, is a progressive neurodegenerative disorder that affects nerve cells in the brain and spinal cord.
